Dobashi et al. found up-regulation of SLC35G2 in Caki-1 and Caki-2 RCC cell lines and tumor samples; additionally, siRNA silencing of SLC35G2 diminished cell growth in those cell lines, suggesting its potential involvement in cancer progression and development [29]. This evidence concerns the gene SLC35G2 and neoplasm.